Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-50243
J Med Chem 2015 Apr 09;587:2958-2966. doi: 10.1021/jm501873p.
Show Gene links Show Anatomy links

Ensemble-based virtual screening for cannabinoid-like potentiators of the human glycine receptor α1 for the treatment of pain.

Wells MM, Tillman TS, Mowrey DD, Sun T, Xu Y, Tang P.


???displayArticle.abstract???
The human glycine receptors (hGlyRs) are chloride-selective ion channels that mediate inhibitory neurotransmission in the brain stem and spinal cord. They are also targets for compounds of potential use in analgesic therapies. Here, we develop a strategy to discover analgesic drugs via structure-based virtual screening based on the recently published NMR structure of the hGlyR-α1 transmembrane domain (PDB ID: 2M6I ) and the critical role of residue S296 in hGlyR-α1 potentiation by Δ(9)-tetrahydrocannabinol (THC). We screened 1549 FDA-approved drugs in the DrugBank database on an ensemble of 180 hGlyR-α1 structures generated from molecular dynamics simulations of the NMR structure of the hGlyR-α1 transmembrane domain in different lipid environments. Thirteen hit compounds from the screening were selected for functional validation in Xenopus laevis oocytes expressing hGlyR-α1. Only one compound showed no potentiation effects; seven potentiated hGlyR-α1 at a level greater than THC at 1 μM. Our virtual screening protocol is generally applicable to drug targets with lipid-facing binding sites.

???displayArticle.pubmedLink??? 25790278
???displayArticle.pmcLink??? PMC4414066
???displayArticle.link??? J Med Chem
???displayArticle.grants??? [+]

Species referenced: Xenopus laevis
Genes referenced: was

References [+] :
Backman, ChemMine tools: an online service for analyzing and clustering small molecules. 2011, Pubmed